Cite
The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.
MLA
Singh-Jasuja, Harpreet, et al. “The Tübingen Approach: Identification, Selection, and Validation of Tumor-Associated HLA Peptides for Cancer Therapy.” Cancer Immunology, Immunotherapy, vol. 53, no. 3, Mar. 2004, pp. 187–95. EBSCOhost, https://doi.org/10.1007/s00262-003-0480-x.
APA
Singh-Jasuja, H., Emmerich, N. P. N., & Rammensee, H.-G. (2004). The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy. Cancer Immunology, Immunotherapy, 53(3), 187–195. https://doi.org/10.1007/s00262-003-0480-x
Chicago
Singh-Jasuja, Harpreet, Niels P. N. Emmerich, and Hans-Georg Rammensee. 2004. “The Tübingen Approach: Identification, Selection, and Validation of Tumor-Associated HLA Peptides for Cancer Therapy.” Cancer Immunology, Immunotherapy 53 (3): 187–95. doi:10.1007/s00262-003-0480-x.